Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trialHeinz Ludwig, R. Flener, R. Kuzmits et al.|European Journal of Cancer and Clinical Oncology|1986Cited by 44
Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative DiseasesHeinz Ludwig, R. Flener, Agostino Cortelezzi et al.|Oncology|2009Cited by 22